Urinary 15&16 - Glomerulonephritis & Diabetic Neuropathy Flashcards
4 features of glomerulonephritis
Definition
Damaged Structures x4
Classification x4
Causes x2
- ) Definition - inflammation of glomeruli
- often involves the immune systen - ) Damaged Structures - one or more can be affected
- capillary endothelium, glomerular basement membrane (GBM), mesangial cells, podocytes - ) Classification - depends on several factors:
- clinical presentaion, histological appearance, diagnosis, primary/secondary - ) Causes - primary or secondary
- primary causes only affects the kidneys
- secondary causes affects the whole body
Nephrotic Syndrome
Aetiology
Clinical Triad
Investigations
Management
1.) Aetiology - podocyte damage leading to glomerular charge-barrier disruption causing protein leakage
- ) Clinical Triad
- proteinuria: >3g/24h in urine OR urine PCR >300
- hypoalbuminaemia: <30 serum albumin
- oedema: periorbital and bilateral pitting leg swelling - ) Investigations
- bloods: FBC, U+Es, albumin, HbA1c
- urinalysis, 24hr urine collection or urinary PCR
- USS guided renal biopsy to confirm the type - ) Management
- fluid overload: diuretics, salt and water restriction
- proteinuria: ACEi or ARBs, also control BP
- minimal change disease: steroids, if no improvement, must be focal segmental glomerulosclerosis instead
- treat potential complications
Causes of Nephrotic Syndrome
Minimal Change Disease
Membranous Nephropathy
Focal Segmental Glomerulosclerosis
- ) Minimal Change Disease - affects mainly children
- reversible so usually no progression to renal failure
- can be fully treated with steroids
- can advance to FSGS - ) Membranous Nephropathy - affects mainly adults
- can be primary (autoimmune) or secondary (caused by other diseases e.g. lymphoma) - ) Focal Segmental Glomerulosclerosis (FSGS) - can affect children and adults
- scarring of small sections of each glomeruli
- circulating factor damaging podocytes
- can progress to renal failure
Complications of Nephrotic Syndrome
Infection Thromboembolism Hyperlipidaemia Hypocalcaemia AKI/Worsening CKD
1.) Infection - due to loss of immunoglobulins
- ) Thromboembolism - loss of ATIII, plasminogen
- stroke, DVT, renal vein thrombosis
- prophylactic dalteparin if albumin <20 - ) Hyperlipidaemia - altered lipoprotein metabolism
- can start patients on a statin
4.) Hypocalcemia - loss of vitamin D
- ) AKI/Worsening CKD
- may require renal replacement therapy if severe
Nephritic Syndrome
Aetiology
Clinical Features
Investigations
Management
1.) Aetiology - disruption of endothelium results in inflammatory response causing damage to the glomerular basement membrane
- ) Clinical Features
- haematuria +/- proteinuria +/- mild-moderate oedema
- proteinuria <3g/24hrs or urine PCR <300
- AKI (↓GFR): rapidly progressive GN
- hypertension - ) Investigations
- bloods: FBC, U+Es, clotting, PSA
- urinalysis, 24hr urine collection or urine PCR
- exclude infection and malignancy for haematuria
- renal biopsy to confirm diagnosis/type - ) Management
- fluid overload: diuretics, salt and water restriction
- proteinuria: ACEi or ARBs, also control BP
- immunosuppressive therapy depending on specific cause of GN, decided by renal +/- resp + rheum
- plasma exchange for anti-GM or ANCA vasculitis
- dialysis in severe AKI due to RPGN
Causes of Nephritic Syndrome
Anti-GBM Disease (Goodpasture's) ANCA-associated Vasculitis SLE Nephritis IgA Nephropathy/Henoch-Schonlein Purpura Post Streptococcal/Infectious
- ) Anti-GBM Disease- antibodies to type 4 collagen in GBM and alveolar basement membrane (rarer)
- pulmonary haemorrhage (haemoptysis) more likely w/ smokers (pre-existing damage to alveolar endothelium)
- can lead to RPGN
- anti-GBM antibodies, pulmonary infiltration on CXR - ) ANCA-associated Vasculitis - small vessel vasculitis
- granulomatosis w/ polyangiitis (GPA), microscopic polyangiitis (MPA), eosonophilic GPA (Churg-Strauss)
- pulmonary and nasopharyngeal involvement –> haemoptysis, nasal ulcers/polyps
- eosinophilic has atopic features + purpura and peripheral neuropathy aswell as eosinophilia
- all have positive ANCA antibodies - ) SLE Nephritis - can be nephritic or nephrotic
- +ve ANA and anti-dsDNA antibodies - ) IgA Nephropathy/Vasculitis/HSP - disease of the skin and mucous membranes
- visible haematuria associated w/ URT or GI infection
- causes purpura rashes (bleeding underneath the skin)
- also often w/ joint pain and abdominal pain - ) Post-Streptococcal GN (Post-Infectious)
- weeks after group A ß-haemolytic strep e.g. post tonsillitis/pharyngitis, impetigo/cellulitis
- low serum C3, + anti-streptococcal antibodies
- biopsy: immune complex deposition (IgG, IgM, C3)
- self-limiting, ACEi/ARB, low sodium diet
Complication and risk factors (8) of diabetic nephropathy
1.) Complication - commonest cause of end stage renal disease (ESRD)
- ) Risk Factors - age, ethnicity, genetics, smoking
- hypertension, hyperglycaemia, duration of diabetes, high level of hyperfiltration
5 pathological changes in diabetic nephropathy
- ) Hyperfiltration and Hypertrophy - occurs early
- related to hyperglycaemia
- glomerular hypertension causes increase in GFR - ) GBM Thickening - increases pore size
- ) Mesangial Expansion - raises intraglomerular pressure
- ) Podocyte Injury
- ) Glomerulosclerosis - scarring of the glomerulus and the small blood vessels
- hyaline in arterioles (arteriolosclerosis)
5 stages of diabetic nephropathy
Hyperfiltration and Hypertrophy Latent Stage Microalbuminuria Overt Proteinuria ESRD
- ) Hyperfiltration and Hypertrophy of Kidneys
- increased GFR - ) Latent Stage
- normal albuminuria
- GBM thickening and mesangial expansion - ) Microalbuminuria - moderate increase in albuminuria
- high urine albumin:creatinine ratio
- GBM thickening and mesangial expansion
- podocyte changes
- GFR returns to normal
- potentially reversible at this stage - ) Overt Proteinuria - severely increased albuminuria
- diffuse histopathological changes
- worsening systemic hypertension
- falling GFR
- irreversible, can only be slowed
5.) End Stage Renal Disease
Management of diabetic nephropathy
Primary Prevention
Managing Microalbuminuria and Proteinuria x5
- ) Primary Prevention - tight glycaemic and BP control
- can reverse initial hyperfiltration and delay worsening
- doesn’t slow GFR loss in overt proteinuria - ) Managing Microalbuminuria and Proteinuria
- RAAS inhibition, tight BP control, statin therapy, CV risk management, moderate protein intake